Employees: 8,347
Size Jyothy Labs (JYOTHYLAB.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $762M, the 702nd largest of 1,066 India companies the cockpit tracks. Shares closed at ₹194.25 on 18 Nov 2026.
Performance Over six months the shares fell 9.0%, against +9.2% for the median peer and +3.8% for the India market (cap-weighted) — 10th lowest of 21 in its peer set.
Growth Revenue grew 4.6% over the last twelve months (peer median +10.2%); the operating margin is 7.6% (peer median 8.8%).
Valuation It trades at 40.8× forward earnings against a peer median of 18.9× (2nd most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 35% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +26 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 0.6 points below its cost of capital (19.1% WACC).
Next results Next results expected around 27 Jan 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹29.9B | ₹29.4B | ₹28.4B | ₹27.7B | ₹25.0B |
| Revenue growth | — | +4% | +3% | +11% | — |
| Gross profit | ₹8.18B | ₹9.45B | ₹10.00B | ₹9.62B | ₹7.02B |
| EBITDA | ₹2.91B | ₹4.58B | ₹5.06B | ₹4.95B | ₹3.31B |
| Net income | ₹2.07B | ₹3.33B | ₹3.71B | ₹3.69B | ₹2.40B |
| Free cash flow | n/a | ₹3.58B | ₹2.69B | ₹4.42B | ₹2.90B |
| Capital expenditure | n/a | ₹669M | ₹581M | ₹371M | ₹355M |
| Total debt | ₹611M | ₹516M | ₹613M | ₹506M | ₹465M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | JYOTHYLAB.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +2.7% | -7.9% | 5th highest of 21 |
| 6-month return | -9.0% | +9.2% | 10th lowest of 21 |
| Distance from 52-week high | -39.1% | -33.6% | 9th lowest of 21 |
| Revenue growth (TTM) | +4.6% | +10.2% | 8th lowest of 21 |
| Operating margin | 7.6% | 8.8% | 9th lowest of 21 |
| Forward P/E | 40.8× | 18.9× | 2nd most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 34.5% | 4.0% | most demanding of 17 |
| Growth delivered (Del g) | +8.9% | +9.5% | 9th highest of 17 |
| Hurdle (Req g minus delivered) | +25.6 pp | -5.7 pp | 2nd most demanding of 17 |
| ROIC minus cost of capital | -0.6 pp | +6.2 pp | 6th lowest of 21 |
| EV / EBITDA | 22.4× | 10.1× | most expensive of 12 |
| Net debt / EBITDA | -2.1× | -0.7× | 2nd least indebted of 12 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jyothy Labs JYOTHYLAB.NS | India | $762M | -9% | +5% | 8% | 40.8× | 34.5% | +8.9% |
| Milbon 4919.T | Japan | $743M | +48% | +8% | 14% | 25.7× | -3.3% | +8.2% |
| Hangzhou Haoyue Personal Care 605009.SS | China | $726M | -18% | +10% | 6% | 17.7× | 4.4% | +7.7% |
| SYoung 300740.SZ | China | $816M | -48% | +14% | 3% | 33.4× | 14.0% | +6.1% |
| Galaxy Surfactants GALAXYSURF.NS | India | $845M | +22% | +30% | 9% | 17.6× | 18.5% | +13.7% |
| Cosmecca Korea 241710.KS | South Korea | $847M | +23% | +42% | 12% | 16.3× | n/a | n/a |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $912M | +13% | +10% | 11% | 27.9× | 3.7% | +10.8% |
| Runben Biotechnology 603193.SS | China | $918M | -30% | +13% | 21% | 18.5× | 1.5% | +28.4% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $933M | +56% | +24% | 5% | 52.5× | 28.5% | +0.8% |
| Noevir 4928.T | Japan | $978M | +7% | -3% | 28% | 20.4× | -12.8% | +4.1% |
| Bajaj Consumer Care BAJAJCON.NS | India | $560M | -24% | +29% | 22% | 19.7× | 14.8% | +5.0% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.04B | +15% | +74% | 18% | 11.8× | 11.3% | +49.0% |
| PZ Cussons PZC.L | United Kingdom | $527M | +13% | +5% | 11% | 12.7× | -2.3% | -2.1% |
| d'Alba Global 483650.KS | South Korea | $1.13B | -55% | +49% | 22% | 12.0× | -6.6% | +53.0% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.17B | -42% | +23% | 8% | 14.4× | -6.1% | +21.2% |
| Qingdao Kingking Applied Chemistry 002094.SZ | China | $454M | -26% | +3% | 4% | n/a | n/a | n/a |
| Edgewell Personal Care EPC | United States | $1.30B | +67% | -10% | 7% | 14.2× | n/a | n/a |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.35B | +27% | 0% | 3% | 37.3× | 28.8% | +22.8% |
| Tianjin Yiyi Hygiene Products 001206.SZ | China | $429M | -15% | -8% | 9% | 19.9× | 1.9% | +6.3% |
| Lafang China 603630.SS | China | $414M | -19% | +5% | 3% | 37.6× | n/a | n/a |
| Intercos ICOS.MI | Italy | $1.43B | +12% | -5% | 9% | 18.9× | 4.3% | +11.5% |